• Associate in the American College of Physicians.
• Ex Executive member of Lebanon chapter of international league against Epilepsy (ILAE).
• Ex-Chairman of the Neurologists and Neurosurgeons Club in Tripoli of Lebanon.

• Neurology course to medical students (Med III & Med IV) in American University of Beirut-Medical Center, Lebanon between 2002 & 2007.
• Professor in the Lebanese university, faculty of public health since 2005.
• Professor in the Jinan University between 2008-2010.

TALKS:

• Dual Indication for Migraine Headache, Abu Dhabi, June 11, 2024
• Only Oral CGRP for Preventing Episodic and Chronic Migraine, 3rd GCC Headache & Pain Summit, Manama, Bahrain, May 30, 2024
• 4th Middle East, Africa & Russia Neuroscience Summit, Abu Dhabi, May 18, 2024
• Dissolving the Line Between Acute and Preventive Treatment, Abu Dhabi, March 27, 2024
• Exploring Key Considerations for Migraine Prevention, Abu Dhabi, February 22, 2024
• Aquipta: New Option for Prevention in Migraine Headache, Abu Dhabi, February 21, 2024
• Migraine: The Mother of All Headaches, Abu Dhabi, February 20, 2024
• One Simple Solution for Many Migraines – Role of Rimegepant, Abu Dhabi, January 23, 2024
• Unravelling the Mystery of Migraines: Shedding Light on the Pain, Abu Dhabi, December 19, 2023
• How to Approach a Patient with Headache, Abu Dhabi, December 13, 2023
• See Migraine in a New Light, Abu Dhabi, October 12, 2023
• One Simple Solution for Many Migraines Patients, Abu Dhabi, October 11, 2023
• Understanding, Managing, and Preventing Migraine Headaches, Abu Dhabi, September 28, 2023
• How to Tame the Migraine Monster: Understanding, Managing Migraine Headaches, Abu Dhabi, September 27, 2023
• Moderator of the 3rd Abu Dhabi Brain Conference, Abu Dhabi, September 15-17, 2023
• Decoding Migraines: Understanding, Triggers, Symptoms, and Treatment, Abu Dhabi, June 22, 2023
• Moderator of the 6th General Neurology Forum: Case Studies in the Management of Migraine: Role of Rimegepant, Abu Dhabi, June 17, 2023
• 6th General Neurology Forum: Approach to Patients with Epilepsy, Abu Dhabi, June 17, 2023
• Free Yourself from Migraine, Abu Dhabi, June 15, 2023
• Addressing the Unpredictability of Migraine, Abu Dhabi, June 13, 2023
• Migraine Medical Forum with Emirates Family Medicine Society: Migraine Acute Treatment Optimization Through Real Clinical Cases, Abu Dhabi, May 30, 2023
• 2nd International Pediatric Neurodisability & Neurorehabilitation: Facts about Epilepsy, Abu Dhabi, May 26-28, 2023
• From Theory to Practice for Anti CGRP, Abu Dhabi, May 4, 2023
• Gepants vs. Triptans: What to Choose, Abu Dhabi, April 6, 2023
• Migraine from A-Z, Abu Dhabi, April 5, 2023
• Management of Migraine in Ramadan with the Power of Eptinezumab, Abu Dhabi, March 21, 2023
• 7th Neurological Disorders Forum: One Simple Solution for Many Migraines Patients and Role of Rimegepant, Abu Dhabi, March 18, 2023
• 3rd Fasting and Neuropsychiatry Conference: One Simple Solution for Many Migraines Patients and Role of Rimegepant, Abu Dhabi, March 4, 2023
• Emgality: From Clinical Trial to Real World Evidence & Clinical Practice, 3rd Fasting and Neuropsychiatry Conference, Abu Dhabi, March 4, 2023
• Moderator of the 3rd Fasting and Neuropsychiatry Conference, Abu Dhabi, March 4, 2023
• New Oral Anti CGRP in Town, Abu Dhabi, February 28, 2023
• Migraine – More than a Headache, Abu Dhabi, February 27, 2023
• 3rd Dubai Neurology Congress: Case Challenge in Status Epilepticus, Dubai, February 25, 2023
• Review on Aleract and Its Indication, Abu Dhabi, February 23, 2023
• 2nd Migraine Master Class: Migraine Management from Lifestyle Modification to New Therapy, January 30, 2023
• Our Clinical Experience with Oral CGRP for Migraine Headache Rx, Abu Dhabi, January 28, 2023
• New Prevention Rx for Migraine Headache, Abu Dhabi, January 18, 2023
• Migraine and Prevention: What to Choose, Abu Dhabi, December 22, 2022
• Hold Back MS: Introducing A New Era of B Cell Therapy in MS, Abu Dhabi, December 12, 2022
• This is a Job for Real Heroes: Eptinezumab for Migraine Headache, Abu Dhabi, November 29, 2022
• Migraine Prevention in Low Frequency Episodic Migraine Headache: Clinical Case Experience, Dubai, UAE, November 27, 2022
• Old vs. New Treatment in Migraine Headache, Abu Dhabi, UAE, November 17, 2022
• Managing Migraine in the 21st Century: Are We There Yet? 9th Neuroscience Update Congress, Abu Dhabi, UAE, November 11-12, 2022
• Dissolving the Line Between Acute and Preventive Treatment for Migraine Headache – Role of Rimegepant, Dubai, UAE, October 28, 2022
• Oral CGRP: One Hand Clinical Experience, Abu Dhabi, UAE, October 26, 2022
• Managing Migraine in the 21st Century: Are We There Yet? 4th Virtual Headache Symposium, Abu Dhabi, UAE, October 22, 2022
• Role of Rimegepant in Migraine Headache, Abu Dhabi, UAE, October 15, 2022
• The Importance of Individualization in Migraine Prevention, Abu Dhabi, UAE, October 5, 2022
• Case Studies in Epilepsy, Abu Dhabi, UAE, September 29, 2022
• CGRP Rx: Is it Worth? Abu Dhabi, UAE, September 14, 2022
• Depression in Neurological Disorders: 5th General Neurology Forum, Virtual Conference, Abu Dhabi, UAE, June 18-19, 2022
• Novel Approach to the Treatment of Epilepsy, Abu Dhabi, June 17, 2022
• Understand the Neurological Complications with Herpes Zoster Infection: Virtual Advisor Board Meeting, Abu Dhabi, May 26, 2022
• Eptinezumab: New Powerful Solution for Impacted Patients with Migraine Headache, Abu Dhabi, UAE, May 24, 2022
• An Update of Approach and Treatment of Migraine Headache, Abu Dhabi, UAE, May 23, 2022
• Managing Migraine in the 21st Century, 2nd Fasting & Neuropsychiatric Disorders, Abu Dhabi, UAE, March 18, 2022
• New Concepts in the Management of Migraine, 2nd Fasting & Neuropsychiatric Disorders, Abu Dhabi, UAE, March 18, 2022
• New AED in Epilepsy Treatment: What to Choose, 2nd Dubai Neurological Hybrid Congress, February 25-27, 2022, Intercontinental Hotel, Festival City, Dubai, UAE
• New CGRP in the Market: What is the Additional Benefit? February 23, 2022
• From Theory to Practice, February 7, 2022
• Moderator of the First Advances in Psychiatry Across Ages Conference, Dubai, February 14-15, 2022
• Moderator for the Second International Eating Disorder Conference, Abu Dhabi, November 26-27, 2021
• CGRP and Migraine: What is the Link? November 1, 2021
• Moderator for the Seventh ELAE International Congress, Abu Dhabi, UAE, October 29-30, 2021
• Moderator for the 3rd Virtual Headache Symposium, Abu Dhabi, UAE, October 15, 2021
• Headache and Migraine and Its Risks in the Summer, United Arab Emirates University, July 11, 2021
• Headaches and Migraine: An Overview, United Arab Emirates University, June 22, 2021
• Targeting CGRP: Is it a New Hope for Migraine Treatment? February 22, 2021
• Old OAC vs. NOAC: What to Choose? December 15, 2020
• We Won’t Stop Until We Stop MS: Review of Finemona Trial, December 10, 2020
• Levetiracetam: A New Hope in Epilepsy, December 3, 2020
• Lasmiditan for Acute Treatment of Migraine, November 26, 2020
• Facts about CGRP, November 11, 2020
• Aimovig: Its Role in Treating Migraines, October 31, 2020
• AED in Epilepsy: What to Choose? August 22, 2020
• Prevention of Migraine Headache, August 12, 2020
• What is New in the Field of MS? May 2020
• Advances in the Treatment of Parkinson’s Disease, December 2019
• Role of Sumatriptan in Migraine, August 2019
• First Seizure: Treat or Not to Treat, Nini Hospital, December 11, 2018
• Neurological Complications of Diabetes Mellitus, American University of Beirut Medical Center, October 9, 2018
• Awareness about Epilepsy, Akkar, April 28, 2018
• Update on Topiramate, Chifaa Hospital, May 31, 2017
• New Era of Treatment of Epilepsy, LOP, October 12, 2017
• Management of First Seizure, Nini Hospital, October 18, 2017
• Update on Neuropathic Pain, March 7, 2016
• Can We Use Levetiracetam as Monotherapy? Monla Hospital, May 2, 2015
• Role of SNRI in Depression, November 2014
• Xarelto vs. Sintrom in AF Patients, March 2013
• Venlafaxine and Depression, April 2012
• Update in Treatment of Migraine Headache, April 2011

• 3rd GCC Headache and Pain Summit, Manama, Bahrain, May 30-31, 2024
• 4th Dubai Neurology Congress, Dubai, February 23-25, 2024
• 8th Menactrims Congress, Abu Dhabi, December 8-9, 2023
• Exploring Optimal Management with CGRP Targeting Treatment, Dubai, September 29-30, 2023
• 3rd Abu Dhabi Brain Conference, Abu Dhabi, September 15-17, 2023
• 2nd GCC Headache and Pain Summit, Dubai, June 3-4, 2023
• 6th General Neurology Forum, Abu Dhabi, June 17, 2023
• 2nd International Pediatric Neurodisability & Neurorehabilitation, Abu Dhabi, May 26-28, 2023
• Epilepsy Chapter Meeting, Intercontinental Hotel, Dubai, May 6, 2023
• 3rd Fasting and Neuropsychiatry Conference, Abu Dhabi, March 4, 2023
• 3rd Dubai Neurology Congress, Dubai, February 25, 2023
• 2nd Migraine Master Class: Migraine Management from Lifestyle Modification to New Therapy, January 30, 2023
• 2nd Advances in Psychiatry Across Ages Conference, Abu Dhabi, January 28-29, 2023
• 1st MS Neon, Dubai, UAE, December 9-10, 2022
• 9th Neuroscience Update Congress, Abu Dhabi, UAE, November 11-12, 2022
• 4th Virtual Headache Symposium, Abu Dhabi, UAE, October 22, 2022
• 2nd Abu Dhabi Brain Hybrid Conference, Abu Dhabi, UAE, September 16-18, 2022
• Less is More in MS Management, Dubai, UAE, September 10, 2022
• Learn MS Academy, Dubai, UAE, September 9, 2022
• 5th CNS Summit, Dubai, UAE, June 10-11, 2022
• GCC Headache and Pain Summit, Dubai, UAE, June 3-4, 2022
• 1st Neuroscience Breath Congress, Dubai, UAE, March 26, 2022
• 1st Advances in Psychiatry Across Ages Conference, Abu Dhabi, January 14-15, 2022
• Sixth MENACTRIMS Congress 2021, Dubai, UAE, December 9-11, 2021
• Emirates Neurology Virtual Conference, February 4-6, 2021
• SAMETA Emgality Virtual Speaker Training, June 11, 2020
• European Academy of Neurology, Oslo, Norway, June 28-July 2, 2019
• MS Masters Forum, Madrid, Spain, April 12-13, 2019
• Experience 20 Years and More Improving MS, Istanbul, Turkey, March 1-2, 2019
• Fourth MENACTRIMS Congress 2018, Dubai, UAE, November 30-December 1, 2018
• The 10th International Congress of the Lebanese Society of Neurology, October 19-21, 2018
• Preceptorship in MS: Patient Treatment and Management, Cemcat Barcelona, Spain, October 15-16, 2018
• 26th European Neurology Congress, Madrid, Spain, August 6-8, 2018
• Third MENACTRIMS Congress 2017, Dubai, UAE, November 23-25, 2017
• Third Near East Forum on Multiple Sclerosis, Yerevan, Armenia, October 4-6, 2017
• 32nd International Epilepsy Congress, Barcelona, Spain, September 2-6, 2017
• Update on Neuropathic Pain and Epilepsy, Bucharest, Romania, July 21-23, 2017
• 2nd Regional Expert Meeting for Therapeutic Botox, Dubai, UAE, May 19-20, 2017
• Update on Depression, Dubai, UAE, September 2016
• 8th International Congress of the Lebanese Society of Neurology, Beirut, Lebanon, November 2016
• 31st International Congress, Istanbul, Turkey, September 2015
• 4th Symposium on Stroke, Cognitive Impairment & Neuropathy Management, Rome, Italy, April 23-24, 2015
• Update on Neuropathic Pain, Prague, Czech Republic, March 2015
• 6th International Congress of the Lebanese Society of Neurology, Beirut, Lebanon, November 21-23, 2014
• European Academy of Neurology Meeting, Istanbul, Turkey, June 2014
• EFNS, Barcelona, Spain, June 2013
• 4th Pain & CNS Academy Middle East Region, Dubai, UAE, January 1-2, 2013
• 7th Educational Epilepsy Symposium, Multiple Sclerosis and Parkinson Disease Update, Beirut, Lebanon, January 17-20, 2013
• 4th International Congress of the Lebanese Society of Neurology, Broumana, Lebanon, October 4-7, 2012
• 22nd Meeting of the European Neurological Society, Prague, Czech Republic, June 9-12, 2012
• First Middle East & North African Symposium on Stroke, Dubai, UAE, March 29-30, 2012
• XX World Congress of Neurology, Marrakesh, Morocco, November 12-17, 2011
• 7th Congress of the European Federation of IASP Chapters, Hamburg, Germany, September 20-24, 2011
• 29th International Epilepsy Congress, Rome, Italy, August 28-September 1, 2011
• Annual Congress of the Cyprus Neurological Society, Limassol, Cyprus, May 13-14, 2011
• From Clinical Trials to Clinical Experience, Budapest, Hungary, April 29-May 1, 2011
• Course in Electro Clinical Syndrome in Infancy, Childhood and Adolescence, Beirut, Lebanon, March 26, 2011
• 14th Congress of the European Federation of Neurological Societies, Geneva, Switzerland, September 25-28, 2010
• Workshop on Botulinum Toxin in Neurology, Phoenicia Intercontinental Hotel, Beirut, Lebanon, June 5, 2010
• XXXIV Middle East Medical Assembly, Beirut, Lebanon, April 22-25, 2010
• Redefining Success in MS: Urgency to Treat, Control & Improve, Lisbon, Portugal, March 19-20, 2010
• The Second East Mediterranean Epilepsy Congress, Dubai, UAE, March 3-6, 2010
• What is New in MS Treatment, Metropolitan Hotel, February 13, 2010
• The MENU Congress, Habtoor Hotel, December 18-19, 2009
• Workshop on Tysabri, Mzaar Intercontinental, March 28, 2009
• Workshop on EEG, Grands Hills, Broumana, December 20-21, 2008
• Workshop on Botulinum Toxin in Movement Disorders, Grands Hills, Broumana, March 24-25, 2008
• EEG Course Held at Saudi German Hospitals, Jeddah, KSA, March 19-20, 2008, in collaboration with Saudi Chapter of Epilepsy
• Workshop on EMG, Grands Hills, Broumana, March 8-9, 2008
• The First East Mediterranean Epilepsy Congress, Luxor, Egypt, February 21-24, 2007
• The First Jordanian Lebanese Joint Epilepsy Meeting, Beirut, Lebanon, June 23, 2006
• XXXX Middle East Medical Assembly, Beirut, Lebanon, May 11-16, 2006
• XXXIX Middle East Medical Assembly, Beirut, Lebanon, May 12-15, 2005
• The 5th Congress of the Pan Arab Child Neurology Association, Beirut, Lebanon, March 31-April 2, 2005
• Regional MS Forum, Beirut, Lebanon, February 11-12, 2005
• First International Meeting of the Lebanese Society of Neurology and the Lebanese League Against Epilepsy, Beirut, Lebanon, November 17-20, 2004
• Depression and Anxiety Disorders, Dubai, UAE, October 2004
• 8th Congress of the European Federation of Neurological Societies, Paris, France, September 4-7, 2004
• XXXVIII Middle East Medical Assembly, Beirut, Lebanon, May 13-16, 2004
• Regional MS Forum, Beirut, Lebanon, March 12-13, 2004

• Mohamad Harb, Ihab El Hajj, Raja Sawaya: Status Epilepticus Secondary to Metronidazole. BMJ Middle East.
• Ihab El Hajj, Mohamad Harb, Raja Sawaya: Acute Progressive Bilateral Carpel Tunnel Syndrome Secondary to an Upper Respiratory Infection. Southern Medical Journal, Nov 2005; 98(11): 1149-51.
• Zaher Otrok, Rami Mahfouz, Ihab El Hajj, Mohamad Harb, Raja Sawaya: Should We Screen Patients for Inherited Thrombophilia Before Starting Thalidomide? American Journal of Clinical Oncology, Feb 2006; 29(1): 100-1.
• B. Uthman, S. Sabbagh, A.R. Shatila, N Akkawi, Y. Makki, Mohamad Harb, A. Beydoun on behalf of the NOEL Study Group: Mimickers of Epilepsy in a Prospective Cohort of Patients with Suspected Newly Diagnosed Epilepsy.
• O. Dabbagh, Mohamad Harb, H. Eid, H. Tfaily, N. Mohsen, R. Hilal, A.R. Shatila on behalf of the NOEL study group: Yield of Epileptiform Discharges after 3 Hours Sleep-Deprived EEG in Newly Diagnosed Patients with Epilepsy.
• Y. Makki, M. Arabi, H. Eid, Mohamad Harb, G. Hmaimess, S. Sabbagh, W. Nasreddine on behalf of the NOEL study group: The Relative Contribution of EEG and Brain MRI to the Diagnosis of Epilepsy.
• Anat Achiron, Hany Aref, Jihad Inshasi, Mohamad Harb, Raed Alroughani, Mhendra Bijarnia, Kathryn Cooke, Ozgur Yuksel: Effectiveness, Safety, and Health-Related Quality of Life of Multiple Sclerosis Patients Treated with Fingolimod: Results from a 12-Month Real-World Observational Performis Study in the Middle East. BMC Neurology, Aug 2017; 17(1): 150.
• Yazan Bader, Reem Suleiman, Mohamad Harb, Vanessa Santos, Ibrahim Al Qaisi, Taoufic Alsaadi: Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study. Neurology Therapeutics, July 7, 2023.

Investigations & Research

• Recap Study with Novartis.
• Real-World Retrospective Study of Effectiveness and Safety of Gilenya in Relapsing Remitting Multiple Sclerosis in the Middle East and North Africa Countries (FINOMENA).

Posters

• Mohamad Harb, Abdul Rahman Shatila, Fouad Zaideh: Ischemic Stroke in a Community Hospital for 2 Years (2000 & 2001).
• Mohamad Harb, Ahmad Beydoun, Tarek Zakaria, Noureddine Baha, Atweh Samir: Pure V1 Trigeminal Neuralgia Secondary to Cataract Surgery. XXXVIII MEMA 2004.
• Ihab El Hajj, Mohamad Harb, Raja Sawaya: Acute Progressive Bilateral Carpel Tunnel Syndrome. XXXVIII MEMA 2004.
• Tarek Zakaria, Mohamad Harb, Atweh Samir: An Atypical Case of Guillain-Barré Syndrome. XXXVIII MEMA 2004.
• Raed Al Roughani, Haitham Elf Dally, Hessa Otaiby, Ahmad Hasan, Zohair Kawi, Mohamad Harb, Magd Zakaria, Mounir Khoury, Tawfiq Saadi, Abdallah Asmi: Real-World Retrospective Study of Effectiveness and Safety of Fingolimod in Relapsing Remitting Multiple Sclerosis in the Middle East and North Africa. Fourth Menactrims Congress, Dubai, Nov 30-Dec 1, 2018.